delete MARKETING AUTHORISATIONS
The Veterinary Medicines Regulations 2006 establish a comprehensive regulatory framework for veterinary medicinal products in the UK, including requirements for marketing authorizations, manufacturing authorizations, wholesale dealer permits, product classification (POM-V, POM-VPS, AVM-GSL), import/export controls, advertising restrictions, record-keeping obligations for food-producing animal keepers, the 'cascade' system for prescribing medicines outside marketing authorization terms, enforcement powers including inspector authorities and seizure procedures, and appeals processes. The regulations implement EU-derived requirements including reference to the European Medicines Agency and incorporate extensive administrative and criminal offence provisions.
These regulations represent a comprehensive bureaucratic authorization regime that creates substantial barriers to entry for veterinary medicines, restricting competition and limiting farmers' and veterinarians' access to products. The marketing authorization requirement, while framed as safety protection, imposes compliance costs that raise prices and reduce availability—particularly harmful given the niche nature of many veterinary markets. The extensive advertising restrictions and import controls impede free trade. The cascade system, while providing a safety valve, reflects a complex authorization system that itself creates the access problem. Record-keeping requirements impose disproportionate compliance burdens on small farms. Most significantly, the regulation was inherited wholesale from EU law with no independent democratic review and contains gold-plating of EU requirements. Post-Brexit regulatory independence provides the opportunity to replace this command-and-control authorization model with a more liberalized regime focused on genuine safety outcomes, liability-based accountability, and free trade principles that Adam Smith would recognize.